AstraZeneca Pharma India gets DCGI nod to market diabetes drug

— October 17, 2017 comments off

The product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca Pharma India said in a statement.